Aurinia Pharmaceuticals Inc. Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
  • Aurinia Pharmaceuticals Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $276K, a 4.94% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Operating Lease, Payments for 2023 was $1.08M, a 6.9% decline from 2022.
  • Aurinia Pharmaceuticals Inc. annual Operating Lease, Payments for 2022 was $1.16M, a 79.6% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Operating Lease, Payments for 2021 was $646K, a 142% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.08M -$80K -6.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $1.16M +$514K +79.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $646K +$379K +142% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $267K +$85K +46.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $182K +$31K +20.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $151K Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.